IMFINZI (durvalumab)injection 120mg/2.4ml

Imfinzi 120mg Injection is an anticancer drug used to treat several cancers, including non-small cell lung cancer, biliary tract cancer, liver cancer, and endometrial cancer. It works by blocking the PD-L1 protein on cancer cells. This allows the immune system to recognize and attack these cells more effectively.

Imfinzi 120mg Injection is administered as an intravenous infusion, typically given in a hospital or a clinical setting. Make sure to attend all scheduled appointments and follow your doctor’s instructions. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help optimize the treatment’s effectiveness.

Common side effects include fatigue, cough, nausea, and loss of appetite. Some patients may experience diarrhea, skin rash, or shortness of breath. If you experience severe or persistent side effects, contact your doctor immediately. Staying hydrated and reporting side effects early can help manage them effectively.

While on Imfinzi 120mg Injection, avoid activities that can increase your risk of infection, such as contact with sick individuals or large crowds. The drug can cause immune-related side effects, such as inflammation of the lungs, liver, or intestines, so report any unusual symptoms promptly.

Imfinzi 120mg Injection is not recommended for individuals with certain autoimmune conditions or those who are pregnant or breastfeeding, as it may pose risks to the fetus or infant. Before receiving this injection, inform your doctor about any other medications you are taking to avoid interactions. Always discuss your medical history and any concerns with your doctor before starting treatment.